Emcure to make Gennova Biopharma wholly owned subsidiary with ₹232 crore stake buyout
Emcure Pharmaceuticals Ltd announced on Monday, July 13, that it will acquire the remaining 12.05% stake in its subsidiary Gennova Biopharmaceuticals Ltd for ₹231.87 crore, making the biotechnology company a wholly-owned subsidiary. In an exchange filing, the pharma company said it has signed share transfer agreements with all individual shareholders of Gennova to acquire 663,865…
